SCHEMBL22148792

SCHEMBL22148792

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc(-c4nc(-n5c6ccccc6c6ccccc65)c(-n5c6ccccc6c6ccccc65)c(-n5c6ccccc6c6ccccc65)c4-n4c5ccccc5c5ccccc54)c3)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
ATM Q13315 2/20 0.34
ACP1 P24666 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
KDM4E B2RXH2 2/20 0.33
DPP4 P27487 3/20 0.33
ABCG2 Q9UNQ0 3/20 0.32
WHR1 P49842 1/20 0.32
ALDH1A1 P00352 2/20 0.32
MAPT P10636 2/20 0.32
HPGD P15428 2/20 0.32
LMNA P02545 2/20 0.32
ACHE P22303 1/20 0.32
USP2 O75604 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22148790 0.91 KMT2A (0.42) MEN1KMT2AATMACP1L3MBTL1
SCHEMBL21888843 0.90 ATM (0.38) MEN1KMT2AATMACP1L3MBTL1
SCHEMBL22148784 0.84 ACP1 (0.33) MEN1KMT2AATMACP1L3MBTL1
SCHEMBL22148791 0.84 TSHR (0.35) MEN1KMT2AATMACP1L3MBTL1
SCHEMBL21888845 0.84 MEN1 (0.41) MEN1KMT2AL3MBTL1KDM4EALDH1A1
SCHEMBL21889501 0.84 MEN1 (0.40) MEN1KMT2AATML3MBTL1KDM4E
SCHEMBL22148646 0.84 L3MBTL1 (0.35) MEN1KMT2AATMACP1L3MBTL1
SCHEMBL21889503 0.81 KDM4E (0.36) MEN1KMT2AATML3MBTL1KDM4E
SCHEMBL21888639 0.81 KMT2A (0.41) MEN1KMT2AATMACP1L3MBTL1
SCHEMBL22148881 0.80 KMT2A (0.43) MEN1KMT2AATMACP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES NDUFV3, NDUFV2, CRY2 MEN1 2193/4885KMT2A 4367/4885ATM 2778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.